BioLife Solutions Inc (BLFS)

Short-term

Turnover ratios

BioLife Solutions Inc's inventory turnover has shown fluctuations over the years, ranging from a low of 1.00 to a high of 5.42. The company's ability to convert inventory into sales has been improving recently, with a consistent increase in the inventory turnover ratio over the past few quarters.

In terms of receivables turnover, BioLife Solutions Inc has seen mixed performance, with the ratio varying from 3.51 to 11.22. The company has shown an overall trend of improvement in collecting receivables efficiently, although there has been some volatility in the ratio over time.

The payables turnover ratio for BioLife Solutions Inc has also shown variability, ranging from 2.25 to 47.01. The company's ability to manage its payables has been somewhat unstable, with a significant spike in the ratio in December 2023, indicating a longer payment period to suppliers during that quarter.

Regarding the working capital turnover, BioLife Solutions Inc's performance has been relatively consistent, with the ratio ranging from 0.35 to 33.93. The company has shown a trend of improving efficiency in utilizing its working capital to generate sales, although there was a significant decline in the ratio in June 2020.

Overall, while BioLife Solutions Inc has demonstrated improvements in inventory turnover and working capital turnover, there are some fluctuations in receivables turnover and payables turnover that warrant further monitoring and analysis for better working capital management.

---

Average number of days

Based on the provided data, we can analyze the activity ratios of BioLife Solutions Inc as follows:

1. Days of Inventory on Hand (DOH):
- The trend in the Days of Inventory on Hand shows fluctuations over the years, ranging from as low as 67.28 days to as high as 364.65 days.
- A lower number of days in inventory indicates efficient inventory management, while a higher number may suggest slower inventory turnover.
- The company experienced a significant decrease in inventory days in June 2022, from 364.65 days to 84.75 days, indicating potential improvements in inventory management efficiency.

2. Days of Sales Outstanding (DSO):
- The number of Days of Sales Outstanding varied over the years, with values ranging from 32.53 days to 103.96 days.
- A lower DSO signifies faster collection of receivables, while a higher DSO may indicate delays in collecting payments from customers.
- The company showed improvements in its DSO from September 2023 (58.20 days) to December 2024 (32.53 days), suggesting enhanced efficiency in collecting receivables.

3. Number of Days of Payables:
- The trend in the Number of Days of Payables demonstrates changes over the years, with values ranging from 7.76 days to 162.53 days.
- A lower number of days of payables implies quicker payment of creditors, while a higher number may indicate extended payment terms.
- BioLife Solutions Inc experienced fluctuations in its payables days, with the highest value recorded in September 2021 (162.53 days) and the lowest in December 2023 (7.76 days), potentially indicating adjustments in payment policies.

Overall, a comprehensive analysis of these activity ratios provides insights into the company's inventory management, accounts receivable collection, and accounts payable practices, highlighting areas of efficiency and potential improvement in its operational processes. Tracking these ratios over time can help assess the effectiveness of the company's working capital management and operational efficiency.

---

Long-term

Based on the data provided for BioLife Solutions Inc, the analysis of long-term activity ratios reveals the following trends:

1. Fixed Asset Turnover:
- The fixed asset turnover ratio measures how effectively a company utilizes its fixed assets to generate sales. BioLife Solutions Inc's fixed asset turnover ratio has been relatively stable over the years, ranging from 4.50 to 25.10.
- There was a significant spike in the fixed asset turnover ratio in December 2023, reaching an exceptionally high level of 25.10. This could indicate a sudden increase in sales relative to the fixed assets employed during that period.
- Overall, the company's fixed asset turnover ratio trended upwards from March 2020 to December 2024, with fluctuations along the way but showing a general improvement in the efficiency of utilizing fixed assets to generate revenue.

2. Total Asset Turnover:
- The total asset turnover ratio shows how efficiently a company uses its total assets to generate sales. BioLife Solutions Inc's total asset turnover ratio fluctuated between 0.14 and 0.37 during the period under review.
- The total asset turnover ratio generally improved from September 2020 to December 2022, indicating an enhanced efficiency in using total assets to generate revenue.
- However, the ratio experienced some slight declines from March 2023 to December 2024, suggesting a potential decrease in the company's ability to generate sales compared to the total assets it holds.

Overall, the analysis of BioLife Solutions Inc's long-term activity ratios suggests that the company has shown improvements in utilizing fixed assets and total assets efficiently to generate revenue, with some fluctuations in performance observed over the years. Monitoring these ratios can provide insights into the company's operational efficiency and asset utilization strategies going forward.